Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sucharita J Mistry

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Molecular Cancer Therapeutics|December 19, 2006
Therapeutic interactions between stathmin inhibition and chemotherapeutic agents in prostate cancerSucharita J Mistry, George F Atweh
The Mount Sinai Journal of Medicine, New York|November 5, 2002
Role of stathmin in the regulation of the mitotic spindle: potential applications in cancer therapySucharita J Mistry, George F Atweh
Molecular Cancer Therapeutics|May 3, 2013
New paradigms in microtubule-mediated endocrine signaling in prostate cancerSucharita J Mistry, William K Oh
Molecular Cancer Research : MCR|August 3, 2007
Synergistic antiangiogenic effects of stathmin inhibition and taxol exposureSucharita J Mistry, Alexander Bank, George F Atweh
Molecular Cancer Therapeutics|December 24, 2005
Targeting stathmin in prostate cancerSucharita J Mistry, Alexander Bank, George F Atweh
Experimental Cell Research|June 16, 2010
Isolation and characterization of a large soluble form of fibronectin that stimulates adhesion, spreading, and alignment of mouse erythroleukemia cellsBarbara M Scher, Sucharita J Mistry, Nasreen S Haque, et al.
Cancer Cell|June 12, 2019
Non-oncogene Addiction to SIRT3 Plays a Critical Role in LymphomagenesisMeng Li, Ying-Ling Chiang, Costas A Lyssiotis, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Molecular Cancer Therapeutics|December 19, 2006
Therapeutic interactions between stathmin inhibition and chemotherapeutic agents in prostate cancerSucharita J Mistry, George F Atweh
The Mount Sinai Journal of Medicine, New York|November 5, 2002
Role of stathmin in the regulation of the mitotic spindle: potential applications in cancer therapySucharita J Mistry, George F Atweh
Molecular Cancer Therapeutics|May 3, 2013
New paradigms in microtubule-mediated endocrine signaling in prostate cancerSucharita J Mistry, William K Oh
Molecular Cancer Research : MCR|August 3, 2007
Synergistic antiangiogenic effects of stathmin inhibition and taxol exposureSucharita J Mistry, Alexander Bank, George F Atweh
Molecular Cancer Therapeutics|December 24, 2005
Targeting stathmin in prostate cancerSucharita J Mistry, Alexander Bank, George F Atweh
Experimental Cell Research|June 16, 2010
Isolation and characterization of a large soluble form of fibronectin that stimulates adhesion, spreading, and alignment of mouse erythroleukemia cellsBarbara M Scher, Sucharita J Mistry, Nasreen S Haque, et al.
Cancer Cell|June 12, 2019
Non-oncogene Addiction to SIRT3 Plays a Critical Role in LymphomagenesisMeng Li, Ying-Ling Chiang, Costas A Lyssiotis, et al.
Pageof 1